For patients with metastatic cancer, the prognosis remains grim and conventional chemotherapy is limited. This book lays out a novel strategy using artificial intelligence and genomic data to develop precise, personalized treatments that offer hope for an eventual cure.
Stephen P. Ethier
Stephen P. Ethier, PhD, is Professor of Pathology and Laboratory Medicine at the Medical University of South Carolina, having previously served as Associate Director for Basic Research and Deputy Director of the Barbara Ann Karmanos Cancer Institute, and Professor of Oncology at Wayne State University, USA. Dr Ethier has spent his entire career studying the biology of breast cancer. In recent years, his work has focused on the genomic alterations that drive breast cancer development and how those genomic changes lead to the expression of malignant phenotypes and drug sensitivities in breast cancer cells. His publications include over 140 peer reviewed scientific papers, and The Lewis Exchange, his first work of fiction.
Author's books
View more
This product has multiple variants. The options may be chosen on the product page
From £29.99
View more
This product has multiple variants. The options may be chosen on the product page